Hepatology
789 articles · 19 journals
Publication dynamics
Journals in this subcategory (19)
- Annals of Hepatology · Elsevier (90)
- Journal of Hepatology · Elsevier (75)
- Journal of Hepato-Biliary-Pancreatic Sciences · Wiley (73)
- HPB · Elsevier (72)
- Gastroenterología y Hepatología · Elsevier (62)
- Gastroenterology · Elsevier (60)
- Journal of Clinical and Experimental Hepatology · Elsevier (59)
- Clinics in Liver Disease · Elsevier (48)
- Cellular and Molecular Gastroenterology and Hepatology · Elsevier (44)
- Journal of Liver Transplantation · Elsevier (44)
- Journal of Gastroenterology and Hepatology (Australia) · Wiley (41)
- The Lancet Gastroenterology & Hepatology · Elsevier (35)
- Liver International · Wiley (34)
- Portal Hypertension and Cirrhosis · Wiley (21)
- Liver Research · Elsevier (19)
- Journal of Viral Hepatitis · Wiley (12)
- Current Hepatology Reports · Springer Nature (0)
- Egyptian Liver Journal · Springer Nature (0)
- Hepatology International · Springer Nature (0)
- From evidence to action: The WHO–Imperial–EASL Collaborating Centre on Steatotic Liver Disease
- MASLD, MASH, and MARCHF6: Introducing a new player in fatty liver disease
- IL-19 limits macrophage-driven inflammation in acetaminophen-induced liver injury
- Decoding primary refractoriness to atezolizumab plus bevacizumab in hepatocellular carcinoma: The myeloid frontier
- Beyond editing: Delivery systems will shape the future of gene therapy for chronic liver disease
- Unveiling the biology of liver fibrosis: A miniseries on the mechanisms, diagnostics, and reversibility of liver fibrosis
- MARCHF6 orchestrates hepatic lipid homeostasis by targeting SREBP1 for ER-associated degradation
- HbA1c trajectories and the risk of liver-related events in patients with type 2 diabetes mellitus
- Dysregulated transcription in core- and pol-specific CD8 T cells can be targeted by HDAC inhibition to improve T-cell function in chronic hepatitis B
- Interleukin-19 ameliorates drug-induced liver injury by limiting proinflammatory macrophage infiltration via SUMOylation of C/EBPβ
- Anserine restores antibacterial immunity in cirrhosis via protective CCL5-mediated hepatocyte-CD44+ pDC crosstalk
- A myeloid immunosuppressive phenotype defines primary refractoriness to atezolizumab plus bevacizumab in hepatocellular carcinoma
- MRI-based prediction of very early recurrence within 1 year after resection of HCC: An international cohort study
- Anti-CCL2-conjugated platelets attenuate early allograft and ischemia–reperfusion injury by inhibiting monocyte infiltration
- In vivo base editing alleviates hepatic iron accumulation and fibrosis in models of HFE-related hereditary hemochromatosis
- Validation of a pan-ELastography Machine-learning (ELM) score to predict clinically significant portal hypertension in compensated advanced chronic liver disease
- The hepato-exposome axis: How endocrine disruptors hijack liver receptors to drive MASLD
- Baveno VIII – Advancing consensus in portal hypertension
- Regression of liver cirrhosis
- Fibrosis regression in chronic liver disease: The pathologist’s view
- From prevalence to programme: Liver fibrosis screening after LiverScreen
- Advancing functional cure for hepatitis B virus infection
- Mitochondrial NAD+ determines the metabolic capacity for liver regeneration
- Difficult diagnoses: Quando è notte, è notte per tutti
- Triple parallel TIPS for porto-sinusoidal vascular disorder with refractory hemorrhage: Portal hypertension, but not as we know it
- Agree to disagree: Increasing the impact of recommendations formulated through Delphi methodology
- Reply to: “Agree to disagree; increasing the impact of recommendations formulated through Delphi methodology”
- Single-nucleus and spatial transcriptomic analyses reveal intra-tissue heterogeneity of PNPLA3
- Reply to: “Single-nucleus and spatial transcriptomic analyses reveal intra-tissue heterogeneity of PNPLA3”
- Role of HBV genotype, monitoring, and events after cessation of nucleos(t)ide analogue therapy